Source: Eur Respir J 2007; 29: 240-250
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Griese M., Latzin P., Kappler M., Weckerle K., Heinzlmaier T., Bernhardt T., Hartl D.. α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur Respir J 2007; 29: 240-250

Member's Comments

No comment yet.

Related content which might interest you: Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Inhaled heparin in cystic fibrosis Source: Eur Respir J 2006; 27: 354-358 Year: 2006 The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Source: Eur Respir J 2009; 34: 655 Year: 2009 Anti-inflammatory cytokines in cystic fibrosis lung disease Source: Eur Respir J 2006; 28: 581-587 Year: 2006 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis Source: Eur Respir J 2012; 39: 297-304 Year: 2012 Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease Source: Eur Respir J 2011; 37: 1378-1385 Year: 2011 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 New insights into the pathophysiology of lung disease in cystic fibrosis patients Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1 Year: 2006 Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 Neutrophil elastase and lung damage in cystic fibrosis Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012 Long-term clearance from small airways in patients with cystic fibrosis Source: Eur Respir J 2005; 25: 317-323 Year: 2005 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004